Transitional Research

  • The discovery and development of novel estrogen-based neuroprotectants for the treatment of Alzheimer’s disease and other age-related disorders
  • Assessment of 17 alpha-estradiol for longevity and vigor during aging
  • Assessment of the uses of methylene blue for treatment of a variety of neurodegenerative diseases
  • The assessment of dietary intervention on stroke, Alzheimer’s disease and other neurodegenerative conditions

Core translational Laboratories

  • Drug Synthesis Core- a collaboration between the UNT Health Center and the Washington University to synthesize and pre-clinically assess novel drugs for effectiveness in Alzheimer’s disease.
  • Mitochondrial Functional Assessment Core-a multiple capacity core for the assessment of the effectiveness of drugs in improving mitochondrial function.
  • Animal Behavioral Assessment Core- an animal core that assesses the effects of aging and Alzheimer’s disease on cognition-related behaviors and evaluated the intervention by diets and drugs.
  • Alzheimer’s Disease Brain Bank-a facility that solicits, collects, evaluates and stores brains from Alzheimer’s disease persons and cognitively normal controls for distribution to researchers.

This page was last modified on March 11, 2015